Company intelligence / Profile preview

Double Rainbow Biosciences

Lexington, Massachusetts, United Statesdoublerainbowbio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company has developed biosynthetic production methods for compounds like Gastrodin (natural analgesic) and Salidroside (adaptogen). They're advancing early-stage assets and preparing to launch their first bioceutical product.

Therapeutic areas: OncologyPsychiatryNeurologyMetabolic Disorders
Modalities: Natural compoundsbiosynthetic compoundsglycosylated compounds
Industry: Biotech

Drug pipeline

1 asset

icariin

Partnerships

Kelai PharmaceuticalsBetta Pharmaceuticals

Beyond the preview

Go deeper on Double Rainbow Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double Rainbow Biosciences.